MedBiome is a biopharmaceutical company based in Canada, founded in 2018. The company's slogan, "Targeting the microbiome to improve human health," reflects its focus on developing novel approaches to inflammatory bowel disease (IBD), Alzheimer's Disease, and colorectal cancer management by leveraging its platform for identification, screening, and development of microbiome modulators. Through patient stratification and the development of microbiome-targeted therapeutic and nutritional approaches, MedBiome aims to make significant strides in the treatment of these conditions. Currently, there is no disclosed information about the last investment and investors in the company.
MedBiome
Targeting the microbiome to improve human health
Founded 2018
Ottawa, Canada
1 employees
Biotechnology, Pharmaceutical
Ottawa, Canada
1 employees
Biotechnology, Pharmaceutical
General Information
Get notified when MedBiome moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track MedBiome
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Canada Market
Biotechnology
About MedBiome
Taxonomy: biopharmaceutical, microbiome modulators, inflammatory bowel disease, Alzheimer's Disease, colorectal cancer, therapeutic approaches, nutritional approaches, compound libraries, bioinformatics, metagenomics, metabolomics, drug development
No funding data available for MedBiome yet.
Get notified when MedBiome raises fundingMedBiome Alternatives & Competitors
MedBiome vs
Cantata Bio
United States
Enabling researchers & clinicians to solve tomorrow’s most challenging problems through novel, multi...
22 employees
MedBiome vs
CHAIN Biotechnology Ltd
United Kingdom
Superior and effective microbiome therapeutics
Seed
8 employees
Biotechnology, Health Care
MedBiome vs
SFA Therapeutics
United States
A New Paradigm in Drug Development
Convertible Note
9 employees
Biotechnology, Health Care
FAQ About MedBiome
Targeting the microbiome to improve human health
MedBiome was founded in 2018.
MedBiome is headquartered in Ottawa, Canada.
MedBiome operates in the following industries: Biotechnology, Pharmaceutical.
MedBiome has approximately 1 employees.
Top alternatives and competitors to MedBiome include Cantata Bio, CHAIN Biotechnology Ltd, SFA Therapeutics, S-Biomedic NV, Halo Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MedBiome and Cantata Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors MedBiome and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
